Ackman reduces Valeant stake, cites taxes
December 31, 2015 at 16:56 PM EST
William Ackman’s Pershing Square Capital Management LP trimmed its stake in Valeant Pharmaceuticals International Inc. to 8.5%, a move the hedge fund said was related to year-end tax planning.
